Department of Radiation Oncology, Cancer Hospital of Guangxi Medical University, Nanning530021, People's Republic of China , zhuxiaodonggxmu@163.com
Abstract: (3364 Views)
The article was first report a case of a 32-year-old female with NPC that is G6PD-deficient. The patient completed induction chemotherapy and concomitant chemoradiotherapy successfully. The patient experienced grade 1 neutropenia , grade 1 diarrhea, and grade 2 acne-like skin reactions during the three cycles of induction chemotherapy. Grade 1 neutropenia, grade 1 diarrhea, grade 2 oral mucositis and grade 1 skin reactions were observed during the concomitant chemoradiotherapy. No hemolytic events were observed. We conclude that it is safe for G6PD-deficient patients with NPC to received chemotherapy and targeted therapy.
Jiang Y, Zhu X. Safe chemotherapy and targeted therapy for
treating locally advanced NPC in a G6PD-deficient patient: case report and literature review
. Int J Radiat Res 2019; 17 (3) :505-508 URL: http://ijrr.com/article-1-2613-en.html